Jan 11, 2003|
It was an eventful week for the stock markets. After starting on a rather lacklustre note, the last two days of the week saw significant volatility in technology stocks. Judging by market reaction, Infosys results were a disappointment. This resulted in the Sensex closing at similar levels as last week.
Before going any further, consider the key gainers and losers on the BSE 'A' group during the week. The top 5 gainers were Lupin, Moser-Baer, Crompton Greaves, Oriental Bank and Aurobindo Pharma. Moser Baer moved up significantly after the European Union relaxed the anti-dumping duty on the company's key growth driver, CD-R's. The stock has gained a stellar 21% during the course of the week. PSU banking
majors were also in the limelight. Apart from Oriental Bank that moved up by 16%, BoB also saw its stock price rise by 12%. PSU banking scrips rallied on the back of stake dilution expectations. But one has to exercise caution over the same, keeping in mind the roadblocks that the divestment process seems to have hit over the last few months.
||Price as on
Jan 10, 2003
|Price as on
Jan 03, 2003
|| 3,758 / 2,828
|| 1,206 / 920
|The bottom 5
|| 70 / 15
|| 57 / 10
|| 393 / 125
|| 73 / 15
|| 4,873 / 2,935
|The top 5
|| 178 / 90
|| 365 / 137
|| 60 / 20
|| 60 / 33
|| 281 / 191
Ashok Leyland was the only noticeable gainer in auto sector. The company posted a 70% rise in volumes sales for December 2002 on the back of a sharp spurt in bus sales (180%) in the same period. Increased demand for higher tonnage vehicles in the southern market combined with higher exports has led this volume growth. Gainers list also include select pharma companies like Dr. Reddy's and Aventis Pharma.
It was however, a dismal week for technology stocks. This is evident from the fact that of the top 10 losers amongst BSE 'A' scrips, 5 were software majors. Silverline, DSQ Software and Hughes Software led the pack. But one has to remember that markets had built-in significant expectations ahead of the quarterly results. The general view was that the management of Infosys would upgrade FY03 earnings upward and see higher client additions. But a 200 basis point decline in margins and a less than expected earnings growth was a big let down, from the stock market perspective. But a large part of the earnings disappointment was on account of spending on internal requirements. Never mind that fact that the company has increased its revenue guidance for FY03. Probably, it is the Wall Street effect that has caught on in the domestic markets. We remain optimistic of the company's long-term growth prospects, as it is well positioned to capitalize on the huge outsourcing opportunity. As far as retail investors are concerned, it is wise to stick to the best of the lot in uncertain times.
Our views on Infy's performance: Infosys: Keep faith!
So, how does the week ahead look like? While it is difficult to predict the course of action for the coming week, the key challenges that India Inc. is facing in the near-term (i.e. 1 year) are there for everyone to see. The possible lag effect of poor agricultural sector performance in 1HFY03 on demand in FY04 and uncertainty over the US-Iraq situation (and thus crude prices) may continue to temper sentiment. While the pre-budget rally could be a possibility, we expect the stock markets to remain range bound in the near-term.
More Views on News
Jun 10, 2017
Forty Indian investing gurus, as worthy of imitation as the legendary Peter Lynch, can help you get rich in the stock market.
Aug 16, 2017
All across the country, the old gods become devils. New, gluten-free gods take their places...
Aug 16, 2017
And what it has in common with beating the stock market too.
Aug 16, 2017
Ensure your financial Independence, and pledge to start the journey towards financial freedom today!
Aug 14, 2017
Last week's correction is making a number of Super Investor stocks look a lot more attractive...
More Views on News
Aug 7, 2017
The data tells us quite a different story from the one the government is trying to project.
Aug 4, 2017
The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.
Aug 8, 2017
Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...
Aug 12, 2017
The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.
Aug 7, 2017
Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...
Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement. LEGAL DISCLAIMER:
Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here
. The performance data quoted represents past performance and does not guarantee future results.SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: email@example.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407